So, during a late-morning break at the Genentech analyst meeting guess who came over to say, "Hey"?
None other than the man himself, Chairman and CEO Art Levinson. He mentioned that he reads the blog and especially liked "My Madoff Moment" post of a couple months ago.
He also complimented me on my work and, most importantly, regarding my campaign to get a sit-down interview with him he said, "Maybe someday."
Hope springs eternal.
I'm at what could be Genentech's last annual investor and analyst meeting. In the future, this could be Roche's show if the Swiss drugmaker pulls off its hostile bid to buy all of Genentech.
Based on my quick scan of the Manhattan Mandarin Oriental banquet room there are between 200 and 300 people here. There are several chairs in the wings that are empty, though. Plus, you never know how many folks are listening to the webcast especially on a day like today when a snowstorm in the northeast could be keeping some people at home telecommuting.
Genentech rather hastily moved up the date of the meeting by a few weeks so that it could spin its case before the Roche tender offer expires in about a week-and-a-half.